Clinical study of lamivudine and Biejia Xiaozheng pill combination therapy for chronic hepatitis B
ObjectiveTo investigate whether supplementation of Biejia Xiaozheng pill increased the therapeutic benefit of lamivudine (LAM) nucleoside analogue drug treatment in patients with chronic hepatitis B virus (HBV) infection. Methods Between June 2009 and June 2012, adult patients (18-60 years old) with...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Department of Journal of Clinical Hepatology
2013-04-01
|
| Series: | Linchuang Gandanbing Zazhi |
| Subjects: | |
| Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=5298&ClassID=31291215 |